Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era

LONDON, Sept. 15, 2016 /PRNewswire/ -- Rescheduling of Hydrocodone combinations from Class III to Class II, clear-cut regulatory guideline for Abuse Deterrent drug formulation NDA & ANDA (solid oral) filing and CDC guideline for Prescribing Opioids for Chronic Pain (2016) are definite...